Inkocell Therapeutics

Inkocell Therapeutics is a Swiss biotech startup developing next-generation cell therapies, focusing on advanced biotechnological treatments for cardiac fibrosis. The company's platform utilizes natural killer (NK) cells to regenerate heart tissue, enabling healthcare providers to offer innovative regenerative therapies for heart disease and related conditions.